Clinical trial
Long-term Prognosis After Thymosin Alpha 1 Treatment in Patients With Sepsis: A Multicenter Cohort Study
NCT04901104 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Prognosis After Thymosin Alpha 1 Treatment in Patients With Sepsis: A Multicenter Cohort Study
- Lead sponsor
- Sun Yat-sen University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- July 1, 2021
- Completion date
- March 31, 2027
- Enrollment
- 900 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
long-term effects of thymosin alpha 1 treatment